Characteristics and outcome of patients with small bowel adenocarcinoma (SBA): research
Small bowel adenocarcinoma (SBA) remains a rare malignancy accounting for less than 5% of all the gastrointestinal tract cancers. However, only limited data and expert guidelines are available for this entity. As a result, treatment concepts are predominantly derived from colorectal cancer.
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
July 2023
|
| In: |
Journal of cancer research and clinical oncology
Year: 2023, Volume: 149, Issue: 8, Pages: 4579-4590 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-022-04344-z |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-022-04344-z Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00432-022-04344-z#citeas |
| Author Notes: | Andreas Teufel, Nadja M. Meindl-Beinker, Pauline Hösel, Michael Gerken, Ana Roig, Matthias P. Ebert, Wolfgang Herr, Alexander Scheiter, Armin Pauer, Hans J. Schlitt, Monika Klinkhammer-Schalke |
| Summary: | Small bowel adenocarcinoma (SBA) remains a rare malignancy accounting for less than 5% of all the gastrointestinal tract cancers. However, only limited data and expert guidelines are available for this entity. As a result, treatment concepts are predominantly derived from colorectal cancer. |
|---|---|
| Item Description: | Online veröffentlicht: 26.September 2022 Gesehen am 30.07.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-022-04344-z |